论文部分内容阅读
目的观察无创呼吸机联合药物治疗对呼吸衰竭患者治疗的临床疗效,进而对无创呼吸机的辅助疗效给予评价。方法将2013年8月-2014年10月收治的呼吸衰竭患者60例随机分为对照组和试验组各30例。对照组采用一般的药物进行治疗,并使其保持呼吸道通畅和有效的通气量;试验组在药物治疗的基础上给予无创呼吸机治疗。比较观察2组患者的临床呼吸衰竭状况。结果治疗后较之对照组,试验组患者的Pa O2值上升幅度明显;Pa CO2值也明显降低,且试验组的p H值比对照组稳定(P<0.05)。试验组总有效率为96.67%明显高于对照组的73.33%(P<0.05)。结论无创呼吸机辅助常规药物治疗能够明显改善呼吸衰竭患者的临床治疗效果,值得大力推广。
Objective To observe the clinical efficacy of noninvasive ventilator combined with medical therapy on patients with respiratory failure and to evaluate the adjuvant effect of noninvasive ventilator. Methods Sixty patients with respiratory failure who were admitted from August 2013 to October 2014 were randomly divided into control group and test group of 30 cases. The control group was treated with general drugs and kept the airway clear and effective ventilation. The experimental group was given noninvasive ventilator treatment on the basis of drug treatment. Comparative observation of two groups of patients with clinical respiratory failure. Results Compared with the control group, the values of Pa O2 in the experimental group increased significantly; the Pa CO2 value also decreased significantly, and the p H value in the experimental group was more stable than that in the control group (P <0.05). The total effective rate of the experimental group was 96.67%, which was significantly higher than that of the control group (73.33%, P <0.05). Conclusion Non-invasive ventilator-assisted conventional drug therapy can significantly improve the clinical efficacy of patients with respiratory failure, it is worth promoting.